Best Researcher Award
Li Wan
Anhui Medical University, China
| Li Wan |
| Affiliation |
Anhui Medical University |
| Country |
China |
| Scopus ID |
57204732623 |
| Documents |
10 |
| Citations |
44 |
| h-index |
3 |
| Subject Area |
Psychology, Psychiatry, Electromagnetic Sensors, Neuroscience, Neuromodulation |
| Event |
Global Sensor Awards |
| ORCID |
0000-0002-3748-9087 |
Li Wan is a Chinese psychologist, neuroscientist, and academic leader recognized for her contributions to brain disorders research, neuromodulation technologies, and non-invasive therapeutic interventions. As Director of the Brain Disorders and Neuromodulation Research Center at Anhui Medical University, she has led multidisciplinary investigations involving electroencephalography (EEG), functional near-infrared spectroscopy (fNIRS), brain-computer interfaces (BCI), transcranial electrical stimulation (tES), and transcranial magnetic stimulation (TMS). Her research spans schizophrenia, major depressive disorder, addiction, cognitive control, and neurorehabilitation, contributing to the development of precision psychiatry and digital biomarkers.[1]
Abstract
Li Wan’s academic career is characterized by interdisciplinary research integrating neuroscience, psychiatry, psychology, artificial intelligence, and neuromodulation technologies. Her work focuses on understanding the neural mechanisms of psychiatric disorders and developing non-invasive therapeutic interventions. Through leadership of multiple provincial and institutional research projects, she has advanced translational neuroscience applications for schizophrenia, addiction, depression, and cognitive dysfunction. Her contributions include the development of EEG-based diagnostic systems, digital biomarkers, and personalized neuromodulation strategies designed to improve clinical outcomes and mental healthcare innovation.[2]
Keywords
Neuromodulation, Psychiatry, Neuroscience, EEG, fNIRS, Brain-Computer Interface, Transcranial Magnetic Stimulation, Transcranial Electrical Stimulation, Schizophrenia, Major Depressive Disorder, Addiction Research, Artificial Intelligence, Cognitive Control, Neuroimaging, Digital Biomarkers.
Introduction
Mental and neurological disorders continue to represent significant global healthcare challenges. Advances in neuroimaging, computational neuroscience, and non-invasive brain stimulation have created new opportunities for understanding and treating these conditions. Within this evolving scientific landscape, Li Wan has established a research program dedicated to identifying neural mechanisms associated with psychiatric disorders while translating laboratory findings into clinically relevant interventions. Her investigations combine neurophysiological measurements with advanced analytical approaches to support precision mental healthcare.[3]
Research Profile
Li Wan earned her Ph.D. in Psychology from Virginia Tech and currently serves as Professor and Director of the Brain Disorders and Neuromodulation Research Center. She has participated in major projects funded by the United States Department of Health and Human Services and the United States Department of Defense. As Principal Investigator, she has led more than ten competitive research projects focused on psychiatric disorders, cognitive neuroscience, neuromodulation technologies, and AI-assisted clinical applications.[4]
- Director, Brain Disorders and Neuromodulation Research Center.
- Professor and Principal Investigator.
- Master’s Supervisor at Anhui Medical University and Wannan Medical College.
- Editorial Board Member of Brain-X, Alpha Psychiatry, and Brain Science Advances.
- Guest Editor, Frontiers in Psychiatry.
- Member of the World Psychiatric Association (WPA).
Research Contributions
Her research portfolio demonstrates sustained contributions toward the understanding of neural circuit dysfunction and therapeutic neuromodulation in psychiatric conditions. Several notable projects include:
- Brain-computer interface interventions for reducing alcohol craving relapse.
- Artificial intelligence-based analysis of adolescent stress during the COVID-19 pandemic.
- EEG frequency modulation approaches for schizophrenia symptom improvement.
- Neural circuit investigations of voluntary inhibition deficits.
- Targeted electrical stimulation approaches for drug dependence treatment.
- Novel neurofeedback systems based on transcranial direct current stimulation.
A significant technological contribution includes the development of an artificial intelligence-assisted EEG medical diagnostic support system, protected under Chinese invention patent ZL 2024 1 0077209.1, demonstrating integration of neuroscience, machine learning, and clinical diagnostics.[5]
Publications
Li Wan has authored or co-authored more than 60 scholarly publications, including over 30 papers indexed in SCI journals. Selected representative publications include:
- Zhang Q., Wan L., et al. (2026). fNIRS identifies right prefrontal hemodynamic signatures for subclassifying alcohol use disorder. Cognitive Neurodynamics.
- Wan L., Chen Y., et al. (2026). EEG-based digital biomarker for personalizing transcranial magnetic stimulation in major depressive disorder. npj Digital Medicine.
- Liu W., Wan L., et al. (2025). The effect of bilateral high-definition γ-tACS on negative symptoms and mismatch negativity in schizophrenia. Journal of Psychiatric Research. DOI: 10.1016/j.jpsychires.2025.05.056
- Wan L., Pei P., Zhang Q., Gao W. (2024). Specificity in the commonalities of inhibition control. European Psychiatry. DOI: 10.1192/j.eurpsy.2024.1785
- Wu H., Zhang Q., Wan L., et al. (2024). Effect of γ-tACS on prefrontal hemodynamics in bipolar disorder. Journal of Psychiatric Research. DOI: 10.1016/j.jpsychires.2024.05.015
Research Impact
The impact of Li Wan’s research extends across neuroscience, psychiatry, clinical psychology, and biomedical engineering. Her studies contribute to improved understanding of cognitive control dysfunction, emotional regulation, and neural network abnormalities associated with psychiatric disorders. By integrating neuroimaging and neuromodulation techniques, her work supports the development of evidence-based personalized treatment strategies and enhances the translation of neuroscience discoveries into clinical practice.[3]
Award Suitability
Li Wan demonstrates strong qualifications for consideration under the Best Researcher Award category. Her record includes leadership of multiple competitive research projects, substantial peer-reviewed publication output, editorial responsibilities in international journals, intellectual property development through an authorized invention patent, and professional service within national and international scientific organizations. The interdisciplinary nature of her work and its translational relevance to mental health care further support recognition of her research achievements.[4]
Conclusion
Li Wan’s scientific career reflects a commitment to advancing knowledge in neuroscience and psychiatry through innovative methodologies and translational research. Her leadership in neuromodulation research, development of AI-assisted diagnostic technologies, and extensive publication record position her among active contributors to contemporary mental health research. Continued investigation of brain disorders and personalized interventions is expected to further strengthen the clinical and scientific significance of her work.
External Links
References
- ORCID. (n.d.). Li Wan Research Profile.
https://orcid.org/0000-0002-3748-9087
- Research Project Portfolio and Award Nomination Documentation submitted by Li Wan (2026).
- Wan, L., et al. Publications in psychiatry, neuroscience, and neuromodulation research (2024–2026).
- Professional Biography and Academic Background, Anhui Medical University.
- China Invention Patent No. ZL 2024 1 0077209.1. Medical diagnostic assistance system based on EEG signals and artificial intelligence classification.